- In January 2025, Bausch + Lomb Corporation, a Europe leader in eye health, has announced the commercial launch of its enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union, following the receipt of a CE Mark. The enVista Aspire lenses feature Intermediate Optimized optics, offering a broader depth of focus compared to traditional spherical and lower-order aspheric IOLs, while maintaining the benefits of the enVista platform. The lenses are glistening-free and use StableFlex Technology for efficient unfolding and optic recovery. For astigmatism patients, the enVista Aspire Toric IOLs provide an effective solution with a +0.90-cylinder design and enhanced rotational stability, designed to treat astigmatism during cataract surgery
